Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.51% | $43.56M | €464.34B | 67.81% | 76 Outperform | |
| AstraZeneca | 2.46% | $30.54M | $288.71B | 29.97% | 79 Outperform | |
| Rolls-Royce Holdings | 1.98% | $24.58M | £102.13B | 124.42% | 71 Outperform | |
| UniCredit SpA | 1.91% | $23.67M | €114.41B | 85.13% | 75 Outperform | |
| Roche Holding AG | 1.54% | $19.15M | CHF279.83B | 49.72% | 73 Outperform | |
| Renesas Electronics | 1.43% | $17.80M | ¥4.58T | 22.49% | 64 Neutral | |
| Siemens | 1.40% | $17.39M | €199.98B | 24.44% | 74 Outperform | |
| Unilever | 1.30% | $16.14M | £107.74B | -5.19% | 72 Outperform | |
| Barclays | 1.27% | $15.76M | £67.09B | 62.14% | 78 Outperform | |
| Mitsubishi UFJ Financial Group | 1.20% | $14.90M | ¥31.36T | 41.66% | 76 Outperform |